In several MAPKi-resistant melanoma cell lines harboring different BRAF or NRAS mutations, the ERK hyperphosphorylation induced by drug withdrawal stimulates the p38-Fra-1-CDKN1A signaling axis, which results in p21 accumulation and proliferative arrest [82]. This evidence concerns the gene BRAF and melanoma.